Porcine Circovirus Type 2 Gene Engineering Subunit Vaccine Antigen

Specification

• Cat#: COV2-384
• Product Name: Porcine Circovirus Type 2 Gene Engineering Subunit Vaccine Antigen
• Species: Porcine Circovirus
• Formulation: No less than 40μg of porcine circovirus type 2 Cap protein per dose (1mL) of vaccine
• Storage: Store at 2-8°C
• Stability: 18 months
• Usage: Intramuscular injection into the neck. Piglets were immunized at 2-4 weeks of age, 1mL/head; Sows are immunized at 2mL/head at 4-5 weeks prenatal.
• Product Overview: Porcine circovirus type 2 (PCV2) can cause Postweaning multisystemic wasting syndrome(PMWS), porcine dermatitis and nephropathy syndrome (PDNS), porcine respiratory disease complex(PRDC), piglet reproductive dysfunction (PRF), piglet congenital tremors (CT) and a series of disease, and easy to mix with other pathogen infection or lead to secondary infection, increased the complexity of clinical. The Porcine Circovirus Type 2 Gene Engineering Subunit Vaccine has multiple immune functions, such as humoral immunity and cellular immunity; And is safer and more efficient because it contains no nucleic acid, with pure antigen and high content; It is a pure virus-like particle circosubunit vaccine; Immunity once, protection all the way.
• Application: For the prevention of diseases caused by porcine circovirus type 2 infection, the immune period is 4 months.
• Adverse Reactions: Generally no adverse reactions. Allergic reactions may occur after injection on sensitive individuals and may be treated with antiallergic drugs (e.g. Dexamethasone, epinephrine, etc.).
• Package: 200 bottles per carton; 80 bottles per carton; 40 bottles per carton; 16 bottles per carton
• Appearance: White suspension. After long standing, there is a small amount of precipitation at the bottom, and the oscillation results in a uniform suspension.